ABSTRACT Objective: A timely initiation of treatment is crucial to better control tuberculosis (TB). The aim of this study is to describe treatment delay among migrant patients with TB and to identify factors associated with treatment delay, so as to provide evidence for strategy development and improvement of TB control among migrants in China.
INTRODUCTION
China has one of the highest burdens of tuberculosis (TB) worldwide and it ranks second among the 22 high-burden countries in the world. 1 Since 1991, China has implemented the Directly Observed Treatment-Short Course (DOTS) strategy and has provided universal coverage for patients with TB. 2 As a result, the cure rate of active TB cases has reached over 90%. 3 However, the implementation of DOTS for the migrant population remains one of the main challenges in China for controlling TB. 4 5 As of 2012, the migrant population in China has reached 236 million, and is expected to increase continuously in upcoming decades. 6 As reported in other studies, TB case management among migrants is more difficult than among local residents due to their 'migratory' nature, poor financial conditions, low education level and minimal awareness of TB. 4 5 7
The challenge of administering to the migrant population presents an important barrier for the National TB Control Program in China. Early detection of cases and timely treatment of TB are essential for effective TB control. [8] [9] [10] [11] Delays occurring in any part of the health-seeking process would increase the probability of TB transmission and eventually result in higher disease burden. 12 Studies of delays have been conducted in many countries, most of which explain the delays in terms of patient delay, diagnosis delay and treatment delay. 13 14 In China, a number of studies have reported the median length of patient delay among migrant patients with TB to last from 10 days in Shandong province 12 to 20 days in Changning District of Shanghai 15 to 43 days in Shijiazhuang city. 16 Previous studies have also reported median diagnosis delays among migrant patients with TB of 5 days in Putuo District of Shanghai 17 to 8 days in Shandong province 12 to 13 days in Changning District of Shanghai. 15 Factors including age, economic
Strengths and limitations of this study
▪ This study is one of the first to try to analyse treatment delay among migrant patients with pulmonary tuberculosis (TB) in China. ▪ A cross-sectional study to examine the treatment delay and its risk factors was conducted in Shandong province of China with recruitment of 314 confirmed smear positive migrant patients with TB. ▪ Economic status and knowledge about TB are key barriers to accessing timely TB treatment among migrants. ▪ The measurement of treatment delay was selfreported, and reporting bias was unavoidable.
status, TB symptoms, health insurance, educational level, working time, and the specific health facilities first visited by the TB patients were found to be associated with the patient and diagnosis delays. 12 15-19 However, to the authors' knowledge, few studies have documented the length of treatment delay, and few have identified risk factors for treatment delay. Therefore, treatment delay among migrants is a high priority among topics for study in China TB control.
The objective of this study is to describe treatment delay among migrant patients with TB in Shandong, China, and to identify factors associated with treatment delay, so as to provide evidence for strategy development and improvement of TB control among migrants in China.
MATERIALS AND METHODS

Study design
This study was conducted in Shandong province, which consists of 140 counties (districts) with a total population of nearly 100 million. By the end of 2008, Shandong had about 6.91 million migrants. The DOTS strategy for TB was introduced in the 1990s and is now available in 100% of counties (districts) in Shandong province. In China, TB cases are usually diagnosed and treated in local TB dispensaries (LTD). However, service providers at other levels, especially the lowest level providers (such as township health centres and clinics) cannot diagnose and treat the TB cases, only to identify suspected TB cases and refer them to the LTD. All diagnosed TB cases (including new and relapsed patients) are required to be registered in the LTD and reported to upper level health authorities.
A total of 12 counties/districts (including Huaiyin District, Lixia District, Dongying District, Guangrao County, Penglai County, Laizhou County, Zouping County, Chengyang District, Jimo County, Luozhuang District, Lanshan District, Gaomi County) were selected as study sites after considering the larger number of migrants in these counties (districts) and the feasibility of the study implementation. The participants were required to meet the following selection criteria: (1) they were smear-positive migrant patients with pulmonary TB registered in one of the LTDs in the 12 sampling sites between 1 August 2007 and 31 July 2008; (2) they had undergone treatment time of over 1 month and (3) they had completed normal treatment, the end of which was within 6 months of initiation.
There were a total of 418 migrant TB patients registered in the 12 sampling sites during the period, 372 of whom met the above criteria. Of the 372 eligible cases, 20 individuals were unreachable because they had left the area, 16 individuals were unresponsive to contact, 11 individuals refused to participate in the study, and 11 individuals did not participate for other reasons. There were 314 patients successfully recruited into the study. Table 1 presents the economic status and distribution of the patients in different sites.
Data collection
A cross-sectional study was conducted between 2 August 2008 and 17 October 2008. The participants were contacted and recruited by staff of the LTD and were interviewed face-to-face at the LTD of the study site using questionnaires that included sociodemographic characteristics, household income, health insurance status, geographic health service accessibility, knowledge about TB and its related policies, and patient health-seeking experiences from diagnosis to the initiation of treatment. The interviews were undertaken by trained postgraduates from the School of Public Health of Shandong University and physicians from the Shandong Center for TB Prevention and Control.
Definitions
In this study, 'migrants' were non-local residents who had already lived or intended to stay in our study areas for at least 3 months. 20 The 'diagnosis symptoms severity' was divided into three categories: mild, moderate and severe. The 'mild symptoms' included the initial symptoms of cough, sputum and night sweats; the 'moderate symptoms' referred to the initial symptoms of chest pain, weight loss and fever; and the 'severe symptoms' included high fever and haemoptysis. 12 Treatment time was the period from the diagnosis of TB to the initiation of treatment. Using the median (1 day) as the cutoff point, a period of longer than 1 day was defined as a treatment delay.
Data analysis
The data were double entered using EPI Data 6.04 and both copies were verified. We used SPSS V.13.0 for Windows to analyse the data. Gender, age, educational level, marital status, residence and health insurance (table 2) . The median of treatment delay was 1 day, with a mean of 2.5 days, ranging from 0 to 90 days. When we examined the treatment delay at the individual level, we found that 65.6% of the participants experienced treatment delay during the study period. The treatment delay was compared across different subgroups using univariate logistic regression analysis. We found that migrant patients with TB who were younger ( p<0.05), who were single ( p<0.05), whose household income levels were lower ( p<0.01), who had a debt ( p<0.01), who were from Dibao households (low-income households identified and subsidised by local bureau of civil affairs-p<0.05), who migrated without families ( p<0.01), whose diagnosis of symptoms was mild ( p<0.01), who thought TB was incurable ( p<0.01) and who did not know about the free TB treatment policy ( p<0.01) were more likely to experience treatment delay (table 3) .
The multivariate logistic regression model indicated that household income level, diagnosis of symptom severity, understanding of whether TB was curable or not and knowledge about the free TB treatment policy were factors significantly associated with treatment delay (table 4) .
DISCUSSION
Providing timely treatment after diagnosis is a key intervention to prevent TB transmission in a community. Therefore, understanding the risk factors for treatment delay is of high significance. The median treatment delay in our study was 1 day, which was similar to the reported median (1 day) among permanent residents in research conducted in Ghana 21 and Ethiopia, 13 and the median (1 day) of delay found in another study among permanent residents in the same study area (Shandong province 22 ), but it was a slightly longer delay than the 0 day median reported among migrant patients with TB in Changning District of Shanghai. 15 Similar to the findings of other studies, this study also indicated that economic status of migrant patients with TB was a key barrier to accessing TB treatment. [23] [24] [25] The policy implemented by the Chinese government to provide free treatment for patients with TB has reached migrants and has, to a certain extent, reduced the financial burden of migrant patients with TB. However, there are also some items that are critical to treating TB among migrants that have not yet been included in the free policy, such as transport costs occurring in the careseeking process and ancillary drugs for treatment. These high out-of-pocket health expenditures may hinder migrant patients with TB from seeking timely TB treatment after diagnosis. Therefore, in order to efficiently reach migrants and make these policies more pro-poor, the free TB control programme should address the economic factors.
When compared with migrant patients who had migrated with their families, we found that patients living alone in the study sites were more vulnerable to treatment delay. Some previous studies found that lack of social support was a positively associated risk factor for TB-related health-seeking behaviour. 26 27 As the most important source of social support for migrant patients with TB, family members played an important role, which could not be replaced by any other sources, in encouraging them to seek timely treatment after TB diagnosis. We found that migrant patients with TB with mild and moderate diagnosis symptoms were more likely to experience treatment delay than those with severe diagnosis symptoms. In China, 80% of migrants are rural-to-urban workers. 28 Among this population, the average educational level is relatively low, 28 which may result in these patients' poor understanding of TB symptoms, importance of timely treatment and the free TB treatment policy, consequently delaying treatment seeking time after diagnosis.
A clear association was observed between treatment delay and patient understanding of the possibility of curing TB. Patients who thought TB was incurable were more likely to experience treatment delay than those who thought TB was curable. We also found that the patients who did not know about the free TB treatment policy were more likely to experience treatment delay. The National TB Control Program Implementation Guide in China (2008) proposed that improving the TB-related understanding level among patients with TB was crucial to controlling TB in China. 29 These findings should therefore give an impetus to carry out TB-related health education and also publicise the free TB treatment policy among migrants.
We were somewhat surprised to observe that health insurance status had no significant effect on the treatment delay among migrant patients with TB. One possible explanation for this finding is the weakness of health insurance policies towards the migrants. In China, the health insurance system is tightly tied to the hukou (household registration) system. Owing to localised management, health insurance is generally not transferrable to a new location. This means that insured migrants are generally unable to utilise local health services. Instead, insured migrants are usually required to return to their hometowns (hukou registered locations) if they want to make use of these benefits. Given the general poor financial conditions of the migrant population, it is unlikely that insured migrants would travel all the way back to their hometowns to utilise these health services. 30 Therefore, the true financial protection level among migrants through health insurance is relatively low, even if they had been covered by some kind of health insurance plans in their hometowns. This finding underlies the need for policymakers to make health insurance plans transferable for migrants.
This study has potential limitations. First, the measure of treatment delay was self-reported and recall bias was thus a serious threat to the estimate of the treatment delay. Similar with other studies, we minimised the estimation error by helping the migrant patients with TB in their recall efforts, and also collecting data from the LTD registration system. Second, the selection of migrant patients with TB might be biased. The target population of this study was patients who had registered in a LTD. This means that patients with undetected TB, patients who had not registered in a LTD and patients who had left the sample counties (districts) during the period of the survey, were not included. This thus affects to some extent the representativeness of our results.
CONCLUSIONS
In this study, 65.6% of participants experienced treatment delay (>1 day). The study indicates that treatment delay was associated with the economic status of migrant patients, which suggests that future policies should extend the range of reimbursement for TB-related health services for the poor among migrant patients with TB to make them more pro-poor. We found that TB patients' poor understanding of the disease was significantly associated with higher treatment delay. This suggests that policymakers should carry out extensive TB-related health education among migrant patients with TB. We also found that factors including diagnosis symptom severity and whether migrants lived with their families were associated with treatment delay. Understanding these risk factors may be helpful for policymakers to make more effective policies targeting the most at-risk patients.
